Is TNGX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TNGX. It does not provide personalized investment advice.

TNGX (Tango Therapeutics, Inc.) Stock Analysis - Financials

Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of September 22, 2026, TNGX trades at $23.88 with a market cap of $3.67B and a P/E ratio of -26.93. TNGX moved +7.41% today. Year to date, TNGX is +152.03%; over the trailing twelve months it is +193.82%. Its 52-week range spans $1.03 to $34.39. Analyst consensus is strong buy with an average price target of $47.71. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TNGX's key financials?

TNGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TNGX recently traded at $23.88. Market cap is $3.67B. P/E ratio is -26.93. Revenue is $53.81M.

TNGX Key Metrics

Key financial metrics for TNGX
Metric	Value
Price	$23.88
Market Cap	$3.67B
P/E Ratio	-26.93
EPS	$-0.84
Dividend Yield	0.00%
52-Week High	$34.39
52-Week Low	$1.03
Volume	1.66M
Avg Volume	0
Revenue (TTM)	$53.81M
Net Income	$-123.72M
Gross Margin	0.00%

TNGX Analyst Consensus

7 analysts cover TNGX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.71.

Common questions about TNGX

What are TNGX's key financials?: TNGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TNGX recently traded at $23.88. Market cap is $3.67B. P/E ratio is -26.93. Revenue is $53.81M.
Is TNGX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TNGX. It does not provide personalized investment advice.